Lamin A/C deficiency as a cause of familial dilated cardiomyopathy

Current Opinion in Cardiology

Volumn 24, Issue 3, 2009, Pages 203-208

  Malhotra, Rohit ^a   Mason, Pamela K ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Familial dilated cardiomyopathy; Lamin A C deficiency; Sudden cardiac death

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LAMIN A; LAMIN C;

APOPTOSIS; AUTOSOMAL DOMINANT INHERITANCE; CLINICAL FEATURE; CONGESTIVE CARDIOMYOPATHY; DISEASE COURSE; FAMILIAL DILATED CARDIOMYOPATHY; FAMILIAL DISEASE; GENE MUTATION; GENETIC SCREENING; HEART ATRIUM FIBRILLATION; HEART DEATH; HEART FAILURE; HUMAN; NONHUMAN; PENETRANCE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN FUNCTION; REVIEW; SUDDEN DEATH; SYMPTOM; ANIMAL; GENETICS;

ANIMALS; CARDIOMYOPATHY, DILATED; GENETIC SCREENING; HUMANS; LAMIN TYPE A;

EID: 67651056405     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/HCO.0b013e32832a11c6     Document Type: Review

References (37)

1. Karkkainen S, Peuhkurinen K. Genetics of dilated cardiomyopathy. Ann Med 2007; 39:91-107. A comprehensive review of the known genetic mutations that have been shown to cause FDC.
2. Fuster B, Gersh BJ, Guiliani ER, et al. The natural history of idiopathic dilated cardiomyopathy. Am J Cardiol 1981; 47:525-531.
3. Michels VV, Driscoll DJ, Miller FA. Familial aggregation of idiopathic dilated cardiomyopathy. Am J Cardiol 1985; 55:1232-1233.
4. Baig MK, Goldman JH, Caforio AP, et al. Familial dilated cardiomyopathy: cardiac abnormalities are common in asymptomatic relatives and may represent early disease. J Am Coll Cardiol 1998; 31:195-201.
5. Grunig E, Tasman JA, Kucherer H. Frequency and phenotypes of familial dilated cardiomyopathy. J Am Coll Cardiol 1998; 31:186-194.
6. Mestroni L, Rocco C, Gregori D, et al. Familial dilated cardiomyopathy: evidence for genetic and phenotypic heterogeneity. J Am Coll Cardiol 1999; 34:181-190.
7. Jakobs PM, Hanson E, Crispell KA, et al. Novel lamin A/C mutations in two families with dilated cardiomyopathy and conduction system disease. J Card Fail 2001; 7:249-256.
8. Hershberger RE, Hanson E, Jakobs PM, et al. Novel lamin A/C mutation in a family with dilated cardiomyopathy, prominent conduction system disease, and need for permanent pacemaker implantation. Am Heart J 2002; 144:1081-1086.
9. van Spaendonck-Zwarts KY, van den Berg MP, van Tintelen JP. DNA analysis in inherited cardiomyopathies: current status and clinical relevance. Pacing Clin Electrophysiol 2008; 31:S46-S49. A review of the use of genetic testing in the evaluation, diagnosis, and treatment of patients with forms of inherited cardiomyopathy.
10. Rankin J, Auer-Grumbach M, Bagg W, et al. Extreme phenotypic diversity and nonpenetrance in families with LMNA gene mutation R644C. Am J Med Genet 2008; 146A:1530-1542. A series of patients with the same missense mutation. This study highlights the variability in penetrance and phenotype for lamin A/C deficiency.
11. Hershberger RE. Familial dilated cardiomyopathy. Prog Ped Cardiol 2005; 20:161-168.
12. Crispell KA, Hanson EL, Coates K, et al. Periodic rescreening is indicated for family members at risk of developing familial dilated cardiomyopathy. J Am Coll Cardiol 2002; 39:1503-1507.
13. Burkett EL, Hershberger RE. Clinical and genetic issues in familial dilated cardiomyopathy. J Am Coll Cardiol 2005; 45:969-981.
14. van Berlo JH, deVoogt WG, van der Kooi AJ, et al. Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A/C mutations portend a high risk of sudden death? J Mol Med 2005; 83:79-83.
15. Meune C, van Berlo J, Anselme F, et al. Primary prevention of sudden death in patients with lamin A/C gene mutations. N Engl J Med 2006; 354:209-210.
16. Taylor MR, Fain PR, Sinagra G, et al. Natural history of dilated cardiomyopathy due to lamin A/C gene mutations. J Am Coll Cardiol 2003; 41:771-780.
17. Sylvius N, Bilinska ZT, Veinot JP, et al. In vivo and in vitro examination of the functional significances of novel lamin gene mutations in heart failure patients. J Med Genet 2005; 42:639-647.
18. Arbustini E, Pilotto A, Repetto A, et al. Autosomal dominant dilated cardiomyopathy with atrioventricular block: a lamin A/C defect-related disease. J Am Coll Cardiol 2002; 39:981-990.
19. Fatkin D, MacRae C, Sasaki T, et al. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conductionsystem disease. N Engl J Med 1999; 341:1715-1724.
20. Gruenbaum Y, Goldman RD, Meyuhas R, et al. The nuclear lamina and its functions in the nucleus. Int Rev Cytol 2006; 226:1-62.
21. Shumaker DK, Kuczmarski ER, Goldman RD. The nucleoskeleton: lamins and actin are major players in essential nuclear functions. Curr Opin Cell Biol 2003; 15:358-366.
22. Sylvius N, Hathaway A, Boudreau E, et al. Specific contribution of lamin A and lamin C in the development of laminopathies. Exp Cell Res 2008; 314:2362-2375. In-vitro study evaluating the effects of lamin A and C overexpression in COS7 cells. The results suggested that different mutations in lamin A and C may cause differential effects on cellular function.
23. Sylvius N, Tesson F. Lamin A/C and cardiac diseases. Curr Opin Cardiol 2006; 21:159-165.
24. van Tintelen JP, Hofstra RMW, Katerberg H, et al. High yield of LMNA mutations in patients with dilated cardiomyopathy and/or conduction disease referred to cardiogenetics outpatient clinics. Am Heart J 2007; 154:1130-1139. A series of patients with FDC who were screened for lamin A/C deficiency. This study found several different mutations that resulted in different clinical courses.
25. Wolf CM, Wang L, Alcalai R, et al. Lamin A/C haploinsufficiency causes dilated cardiomyopathy and apoptosis-triggered cardiac conduction system disease. J Mol Cell Cardiol 2008; 44:293-303. This mouse model study demonstrated a possible mechanism for the clinical presentation of lamin A/C deficiency. Lamin A/C-deficient myocytes demonstrated apoptosis, particularly in conducting cells.
26. Becane HM, Bonne G, Varnous S, et al. High incidence of sudden death with conduction system and myocardial disease due to lamins A and C gene mutation. Pacing Clin Electrophysiol 2000; 23:1661-1666.
27. van Tintelen JP, Tio RA, Kerstjens-Frederikse WS, et al. Severe myocardial fibrosis caused by a deletion of the 5′ end of the lamin A/C gene. J Am Coll Cardiol 2007; 49:2430-2439. A family study demonstrating the malignant course that many patients with lamin A/C deficiency experience. The patients were at high risk forCHFand sudden death.
28. de Backer J, van Beeumen K, Loeys B, Duytschaever M. Expanding the phenotype of sudden cardiac death - an unusual presentation of a family with a lamin A/C mutation. Int J Cardiol 2008. [Epub ahead of print] A family study that demonstrated that the risk of SCD preceded the development of left ventricular dysfunction.
29. Pasotti M, Klersy C, Pilotto A, et al. Long-term outcome and risk stratification in dilated cardiolaminopathies. J Am Coll Cardiol 2008; 52:1250-1260. A large series of 164 patients in 27 families with lamin A/C deficiency. These patients had a malignant course. The authors were able to identify several markers for risk of sudden death, including CHF, which is in contrast to previous studies. Athleticism was also a risk factor for sudden death.
30. Parks SB, Kushner JD, Nauman D, et al. Lamin A/C mutation analysis in a cohort of 324 unrelated patients with idiopathic or familial dilated cardiomyopathy. Am Heart J 2008; 156:161-169. A large series of patients who were found to have lamin A/C deficiency. Multiple different mutations were found with multiple different phenotypes. Not all affected family members were found to have the mutation, suggesting that not all lamin A/C defects cause disease.
31. Perrot A, Hussein S, Ruppert V, et al. Identification of mutational hot spots in LMNA encoding lamin A/C in patients with familial dilated cardiomyopathy. Basic Res Cardiol 2009; 104:90-99. A series of patients with FDC who were found to have lamin A/C deficiency. Two novel mutations were found and mutational hot spots were identified.
32. Rudenskaya GE, Polyakov AV, Tverskaya SM, et al. Laminopathies in Russian families. Clin Genet 2008; 74:127-133. A series of patients with lamin A/C deficiency who were genetically screened. Several novel mutations were discovered and mutational hot spots were identified.
33. Crispell K, Wray A, Ni H, et al. Clinical profiles of four large pedigrees with familial dilated cardiomyopathy: preliminary recommendations for clinical practice. J Am Coll Cardiol 1999; 34:837-847.
34. Michels VV, Moll PP, Miller FA, et al. The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. N Engl J Med 1992; 326:77-82.
35. Koikkalainen JR, Antila M, Lotjonen JMP, et al. Early familial dilated cardiomyopathy: identification with determination of disease state parameter from cine MR image data. Radiology 2008; 249:88-96. MRI was used to screen for preclinical findings in a series of patients with lamin A/C mutations who did not have clinical disease.
36. Jerosch-Herold M, Sheridan DC, Kushner JD, et al. Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy. Am J Physiol Heart Circ Physiol 2008; 295:H1234-H1242. MRI was used to evaluate alterations in blood flow in a series of patients with IDC or FDC.
37. Carboni N, Mura M, Marrosu G, et al. Muscle MRI findings in patients with an apparently exclusive cardiac phenotype due to a novel LMNA gene mutation. Neuromuscul Disord 2008; 18:291-298.